

Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with...
You can purchase shares of Smith & Nephew (NYSE:SNN) through any online brokerage.
Other companies in Smith & Nephew’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Smith & Nephew has a consensus price target of $31.50.
The stock price for Smith & Nephew (NYSE: SNN) is $29.95 last updated November 20, 2026 at 3:01 AM EST.
There are no upcoming dividends for Smith & Nephew.
Smith & Nephew does not have any upcoming earnings scheduled.
There is no upcoming split for Smith & Nephew.
Smith & Nephew is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports...